Delivery Order SPE2DB22D2206-SPE2DB25FJP72
Award Date 8/22/25
Potential Completion Date 8/25/25
Potential Value $35K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order totaling $6,647.56 to AmerisourceBergen Drug Corp for the supply of Ontruzant 420 mg vials. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on August 4, 2025, with a final delivery date of August 5, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ontruzant 150 mg vials, a biosimilar therapeutic product. This firm fixed-price delivery order, valued at $6,850.25, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The ultimate...
- The Defense Logistics Agency awarded a $28,115.42 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ontruzant 420 mg vials, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Ontruzant is a biosimilar to Herceptin used in oncology treatments, reflecting AmerisourceBergen's role...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $34,823.14 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The order is for the supply of the pharmaceutical product ONTRUZANT 420 MG VIALS, with a period of performance through April 5, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $5,621.75 firm fixed-price contract is for the delivery of ONTRUZANT 150 MG VIALS, a pharmaceutical product, with a performance period through May 12, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ONTRUZANT 150 MG vials, with a completion date of March 6, 2024 and a potential value of $1,436.46. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is the prime contractor and has...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $117,365.33 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order was issued on August 16, 2025, with an ultimate completion date of August 18, 2025. The contract represents a child award under AmerisourceBergen's broader relationship with the federal government's military healthcare...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $277,238.46 to AmerisourceBergen Drug Corp on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, issued under a competitive process with no set-aside designation, represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The award leverages the vendor's comprehensive pharmaceutical and...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $34,548.36 to AmerisourceBergen Drug Corp on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price delivery order, issued under a non-competitive set-aside designation, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,447.93 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a competitively awarded, non-set-aside contract. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...